Crinetics Pharmaceuticals, Inc. (CRNX)

53.18 -1.77 (-3.22%) USD  |  NASDAQ  |  Jan 23, 16:00
53.20 +0.02 (+0.04%) After-Hours: 20:00
More

Crinetics Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share)

Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Chart

View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Range, Past 5 Years

View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Benchmarks

View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. --
Axsome Therapeutics, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade
Gossamer Bio, Inc. Upgrade